refactoring-guide

Impact analysis for refactoring in validated clinical trial systems involves identifying all dependencies and classifying affected components based on GxP criticality. This process ensures system integrity is maintained before any code changes are implemented.

Change control documentation for GxP compliant refactoring provides regulatory traceability for all code modifications. It generates necessary templates to prove that validated behavior is preserved and changes receive proper approval before deployment.

Assessing regression risk when refactoring validated EDC software requires evaluating proposed changes against a standardized risk matrix. This evaluation suggests specific mitigation strategies to prevent altering previously validated behavior during the refactoring process.

You can refactor core functions in Talosix EDC software without losing the validated state by following a structured approach that includes impact analysis, risk assessment, and generating change control documentation to ensure regulatory compliance.

You need to perform a GxP criticality classification before refactoring whenever code changes affect dependencies within validated clinical trial systems. This classification identifies which components require strict change control documentation and regression risk evaluation.